When cancer cells break down quickly in the body, levels of uric acid, potassium, and. We define a case of a 70yearold woman patient who was found to have mm. Evolving concepts in tumour lysis syndrome management. Imatinibassociated tumor lysis syndrome in a patient with. Cell lysis results in the release of intracellular ions, nucleic acids, proteins and their metabolites into the systemic circulation. Blood cancers constitute the vast majority of tls cases because of the sensitivity to therapy and rapid division rates. Usually occurs in patients with bulky, rapidly proliferating, and. Tumor lysis syndrome in patients with chronic lymphocytic leukemia. Catabolism of the nucleic acids to uric acid leads to hyperuricemia, and the marked increase in uric acid excretion can result in the. Sep, 2016 tumour lysis syndrome september, 2016 may 22, 2017 martin kuuskne this case is written by dr.
Henry hongrong cai, medical director, pharmacovigilance and drug safety, inventiv health clinical, 95 cynthia road newton, ma 02459, usa, tel. It is caused by the death, or lysis, of large numbers of cancer cells. Tumor lysis syndrome tls is a rare complication of oncologic treatments in solid tumors. Tumor lysis syndrome following trastuzumab and pertuzumab for. This can cause heart or kidney problems and lead to kidney failure. Tumor lysis syndrome american society of nephrology.
This includes tumors that have a high proliferation rate, are highly. As a result, tls can pose potentially lifethreatening. Tumor lysis syndrome tls is one of the metabolic oncologic emer. Tumor lysis syndrome hematology jama oncology jama network. Spontaneous tumour lysis syndrome in a multiple myeloma.
A literature search identified published phase iiii clinical trials of monoclonal antibodies otlertuzumab, brentuximab, obinutuzumab, ibritumomab. Tls is most frequently a result of cancer treatment in combination with a large tumor burden, but has occasionally been reported to occur spontaneously, especially in cases of. Tumor lysis syndrome tls is a rare complication during the. Tumor lysis syndrome american academy of pediatrics.
Tumor lysis syndrome inpatient care what you need to know. Catabolism of the nucleic acids to uric acid leads to hyperuricemia. Jun 16, 2016 tumor lysis syndrome tls is a rare complication of oncologic treatments in solid tumors. The prevalence varies among different malignancies. Tumor lysis syndrome in the era of novel and targeted. Full text prevention and treatment of tumor lysis syndrome, and the.
Acute leukemia knowledge for medical students and physicians. Why it matters tumor lysis syndrome is a constellation of metabolic disturbances that can occur as a potentially fatal complication of treating cancers, most notably leukemias or solid. An elevated pretreatment lactate dehydrogenase ldh level, which correlates with high. Patients at highest risk are those with bulky, rapidly proliferating tumors that are sensitive to treatment. Tls is an oncologic emergency caused by the rapid and massive breakdown of tumor cells, either spontaneously or after the initiation of cytoreductive therapy. Tumor lysis syndrome is a lifethreatening complication of chemotherapy for patients with leukemia and large tumors with a high proliferative index, such as burkitts lymphoma. Tumour lysis syndrome in patients with chronic lymphocytic. Pdf tumor lysis syndrome in primitive neuroectodermal tumor. This occurs most commonly after the treatment of lymphomas and leukemias.
Clinicians should stratify every hospitalized cancer patient and especially those receiving chemotherapy for the risk of tumor lysis syndrome. Managing tumor lysis syndrome in the era of novel cancer. Tumor lysis syndrome symptoms, causes, guidelines and treatment. Tumor lysis syndrome can occur as a consequence of tumor targeted therapy or spontaneously. Tls can become lifethreatening if is not managed or treated. Tumor lysis syndrome tls is an oncologic emergency with a constellation of laboratory findings that result from the lysis of cancer cells. A literature search identified published phase iiii clinical trials of monoclonal antibodies otlertuzumab, brentuximab, obinutuzumab, ibritumomab, ofatumumab. Tumor lysis syndrome an overview sciencedirect topics. However, their propensity to cause tumor lysis syndrome tls has not been systematically examined. Guidelines for the management of pediatric and adult tumor. Tumor lysis syndrome caused by therapeutic monoclonal. Tumor lysis syndrome can occur in any patient with newly diagnosed or relapsed cancer, so all patients should undergo risk stratification. Tumor lysis syndrome tls is an oncologic emergency that is caused by massive tumor cell lysis with the release of large amounts of potassium, phosphate, and nucleic acids into the systemic circulation. Mar 14, 2016 published on mar 14, 2016 this is part of the oncological emergencies in critical care for our senior residents.
Imatinibassociated tumor lysis syndrome in a patient with myeloid. What is the global incidence of tumor lysis syndrome tls. Tls is most frequently a result of cancer treatment in combination with a large tumor burden, but has occasionally been reported to occur. Cancer cells killed by therapy treatment may spill intracellular contents which may then accumulate faster than eliminated causing electrolyte and metabolic disturbances resulting to tumor lysis syndrome. Tumor lysis syndrome is a group of metabolic abnormalities that can occur as a complication during the treatment of cancer, where large amounts of tumor cells are killed off lysed at the same time by the treatment, releasing their contents into the bloodstream.
Laboratory tumor lysis syndrome is the presence of two or more of the following abnormalities present on the same day. This condition is a group of symptoms and a complication from cancer treatment. Health, general evidencebased medicine health care costs control heart kidney diseases care and treatment prevention medical care, cost of medical research medicine, experimental physicians practice rasburicase risk assessment. Recognize lymphomaassociated oncologic emergencies. Dying cells release large amounts of potassium, phosphate, and uric acid into the blood. Tumor lysis syndrome tls is one of the metabolic oncologic emergencies identified by the oncology nursing society. Tumor lysis syndrome symptoms, causes, guidelines and.
Standardized guidelines, however, are needed to aid in the stratification of patients according to risk and to establish prophylaxis and treatment recommendations for patients at risk or with established tls. It results from rapid lysis of tumor cells and release of intracellular materials into the bloodstream. Tumor lysis syndrome tls is an oncologic emergency that is usually seen when tumor cells undergo rapid decomposition spontaneously or, more often, in response to cytoreductive therapy with the release of large amounts of potassium, phosphate, and nucleic acids into the systemic circulation. Identify clinical parameters that can be used to predict the nonbenign nature of lymphadenopathy.
Tumor lysis syndrome caused by therapeutic monoclonal antibodies approved by fda author. Copyright 2016 by the american society of nephrology. May 04, 2015 tumor lysis syndrome is an oncometabolic emergency resulting from rapid cell death. For haematological malignancies, targeted therapies, such as small molecule inhibitors and monoclonal antibodies, have a high antitumour activity, are well tolerated, and have a low incidence of associated tumour lysis syndrome. Tumor lysis syndrome is a condition that tends to be precipitated after a cancer treatment. Tumour lysis syndrome is a complication of chemotherapy for haematological malignancies. The tumor lysis syndrome is the most common diseaserelated emergency in children and adults with hematologic cancers. Tumor lysis syndrome following trastuzumab and pertuzumab. Tumor lysis syndrome tls is an oncologic emergency that is caused by massive tumor cell. Aug 25, 2008 tumor lysis syndrome is more common in patient care situations where there is a faster production and lysis of tumor cells. Pdf tumor lysis syndrome tls is an oncologic emergency due to the rapid lysis of tumor cells and subsequent release of large amounts of.
Prevention and treatment of tumor lysis syndrome, and the efficacy. Tumor lysis syndrome tls is an oncologic emergency that is caused by massive tumor cell lysis with the. Tumour lysis syndrome tls is a lifethreatening oncological emergency. Tls can occur spontaneously before cancer treatment but is more common within a week of starting treatment. A 78yearold man was found to have smallcell carcinoma of the lung with multiple metastases to liver. Tumor lysis syndrome shouldnt be taken lightly for it can provide grave effects. Tumor lysis syndrome tls is a constellation of metabolic. The rapid destruction of tumor cells leads to a massive release of intracellular components, which subsequently damage the kidneys and may cause potentially lifethreatening renal failure. Spontaneous tls is uncommon occurrence in multiple myeloma mm. Tumor lysis syndrome tls is a potentially lifethreatening condition that occurs in oncologic and hematologic patients with large tumor burden. Tumor lysis syndrome is an oncometabolic emergency resulting from rapid cell death. Pdf tumor lysis syndrome tls consists of a triad of hyperuricemia hyperphosphatemia and hyperkalemia along with secondary. Recognize genetic and environmental factors contributing to development of lymphoma. This algorithm has been developed for md anderson using a multidisciplinary approach considering circumstances particular to md andersons specific patient population, services.
Customize your jama network experience by selecting one or more topics from the list below. Tumor lysis syndrome tls was first described in 1929 by bedrna and polcak in patients with chronic leukemia. Preventive measures for tumor lysis syndrome see prophylaxis below tumor lysis syndrome tls 38 description. The tumor lysis syndrome tls is a collection of metabolic abnormalities that occur in consequence of the release of intracellular contents following lysis of tumor cells.
This algorithm has been developed for md anderson using a multidisciplinary approach considering circumstances particular to md andersons specific patient population, services and structure, and clinical information. Tumor lysis syndrome and metastatic melanoma springerlink. It can occur spontaneously or after chemotherapy or radiotherapy. We would like to report an additional case recently seen in our facility. Tumor lysis syndrome tls in adult patients page 1 of 7 disclaimer. Jan 12, 2016 effective new treatments are now available for patients with hematologic malignancies. Tls can occur as a result of cancer treatment or spontaneously. Control of plasma uric acid in adults at risk for tumor lysis syndrome. Tumor lysis syndrome hematology jama oncology jama.
Published on mar 14, 2016 this is part of the oncological emergencies in critical care for our senior residents. Dec 21, 2017 the pattern of metabolic derangements known as tumor lysis syndrome tls was first described decades ago with the introduction of chemotherapy into clinical practice. This is typically seen in hematologic cancers, but can be seen more rarely in solid tumor diseases. Tumor lysis syndrome is a rare case that may happen rapidly or spontaneously. The pattern of metabolic derangements known as tumor lysis syndrome tls was first described decades ago with the introduction of chemotherapy into clinical practice.
Tumor lysis syndrome tls in adult patients page 1 of 7. The authors emphasized very well the fundamental points in taking preventive and curative care in. Pdf tumor lysis syndrome tls is an oncologic emergency from the intracellular release of. Diagnose tumor lysis syndrome and propose prophylactic and therapeutic interventions.
Which patients are at the highest risk for tumor lysis. We report a case of tls which occurred after a single dose of trastuzumab and pertuzumab in the context of metastatic breast cancer in a chemonaive. We have read with great interest the recently published guidelines for the management of tumour lysis syndrome tls jones et al, 2015. Adverse effects of chemotherapy may also require urgent intervention eg, extravasation and anaphylactic reactions. Changes in blood chemistries consistent with tls that require prompt management can occur as early as 6 to 8 hours following the first dose of venclexta and at each dose. Risk assessment and prophylaxis for tumor lysis syndrome. Tumor lysis syndrome risk stratification based on cancer, treatment, and patient. Tls is commonly reported in hematological malignancies with rapid cell turnover rates, but is relatively rare in solid tumors. Tumor lysis syndrome tls is characterized by a massive tumor cell death leading to the development of metabolic derangements and target organ dysfunction. Tumor lysis syndrome tls is a lifethreatening oncologic emergency that occurs when. Tumor lysis syndrome definition of tumor lysis syndrome by.
Common trends of treatment have also been seen in the past several years, evident by case. Recognizing and preventing tumor lysis syndrome ce article. Tumor lysis syndrome tls is an acute, lifethreatening disease among. Pdf current understanding of tumor lysis syndrome researchgate. Purpose tumor lysis syndrome tls has recently been subclassified into either laboratory tls or clinical tls, and a grading system has been established. Guidelines for the management of pediatric and adult tumor lysis syndrome. Tumor lysis syndrome definition of tumor lysis syndrome. An elevated pretreatment lactate dehydrogenase ldh level, which correlates with.
926 1421 260 287 1325 911 934 264 987 1272 18 1401 569 1277 206 122 659 538 1168 213 1040 621 1363 870 1409 786 1193 573 475 1113 15 1503 21 1064 279 372 1371 1085 534 1098 125 1342 1129 178